Peng Zhang-Peng
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Neoadjuvant Chemoimmunotherapy Followed by Surgery or Radiotherapy for Stage IIIA-B Non-Small Cell Lung Cancer With Bulky N2 Disease.
Journal: The Annals of thoracic surgery
Published: August 21, 2025
Multi-omics profiling unveils biological and clinical insights into pulmonary sarcomatoid carcinoma.
Multi-omics profiling unveils biological and clinical insights into pulmonary sarcomatoid carcinoma.
Journal: Cell reports. Medicine
Published: May 23, 2025
Surgery after induced anti-PD-L1 therapy and chemotherapy for stage I‒III small-cell lung cancer: a phase 2 trial (LungMate-005).
Journal: Cell discovery
Published: February 12, 2025
Neoadjuvant camrelizumab plus chemotherapy or apatinib for resectable stage IIA-IIIA NSCLC: a multicenter, two-arm, phase II exploratory trial.
Journal: BMC medicine
Published: December 01, 2024
Short-term intra- and peri-tumoral spatiotemporal CT radiomics for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
Journal: European radiology
Published: November 09, 2024
Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities.
Journal: Experimental hematology & oncology
Published: June 26, 2024
Selective inhibition of TGF-β-induced epithelial-mesenchymal transition overcomes chemotherapy resistance in high-risk lung squamous cell carcinoma.
Journal: Communications biology
Published: June 01, 2024
MAZ promotes tumor proliferation and immune evasion in lung adenocarcinoma.
Journal: Oncogene
Published: May 21, 2024
Anti-PD1 based precision induction therapy in unresectable stage III non-small cell lung cancer: a phase II umbrella clinical trial.
Journal: Nature communications
Published: April 22, 2024
Last Updated: 09/26/2026